JCRファーマの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2020/03/13 | 7,140 | 7,380 | 6,860 | 7,290 | -640 | -8.1% | 324,000 |
2020/03/12 | 8,200 | 8,360 | 7,850 | 7,930 | -410 | -4.9% | 186,400 |
2020/03/11 | 8,830 | 8,890 | 8,310 | 8,340 | -570 | -6.4% | 168,800 |
2020/03/10 | 8,580 | 8,990 | 8,130 | 8,910 | +180 | +2.1% | 229,300 |
2020/03/09 | 9,100 | 9,240 | 8,700 | 8,730 | -790 | -8.3% | 156,800 |
2020/03/06 | 9,590 | 9,710 | 9,470 | 9,520 | -200 | -2.1% | 114,000 |
2020/03/05 | 9,610 | 9,940 | 9,550 | 9,720 | +230 | +2.4% | 126,700 |
2020/03/04 | 9,500 | 9,690 | 9,430 | 9,490 | -300 | -3.1% | 181,600 |
2020/03/03 | 10,660 | 10,660 | 9,790 | 9,790 | -120 | -1.2% | 162,900 |
2020/03/02 | 9,500 | 10,080 | 9,470 | 9,910 | +320 | +3.3% | 144,400 |
2020/02/28 | 9,580 | 9,820 | 9,300 | 9,590 | -330 | -3.3% | 208,400 |
2020/02/27 | 10,450 | 10,480 | 9,810 | 9,920 | -650 | -6.1% | 219,100 |
2020/02/26 | 10,500 | 10,610 | 10,380 | 10,570 | -40 | -0.4% | 130,300 |
2020/02/25 | 10,510 | 10,760 | 10,480 | 10,610 | -450 | -4.1% | 164,400 |
2020/02/21 | 10,970 | 11,300 | 10,960 | 11,060 | +30 | +0.3% | 225,000 |
2020/02/20 | 10,610 | 11,160 | 10,570 | 11,030 | +620 | +6% | 247,500 |
2020/02/19 | 10,320 | 10,520 | 10,320 | 10,410 | +110 | +1.1% | 74,500 |
2020/02/18 | 10,660 | 10,710 | 10,250 | 10,300 | -360 | -3.4% | 92,900 |
2020/02/17 | 10,500 | 10,770 | 10,410 | 10,660 | +240 | +2.3% | 169,700 |
2020/02/14 | 10,400 | 10,520 | 10,230 | 10,420 | +460 | +4.6% | 208,300 |
2020/02/13 | 9,950 | 10,040 | 9,800 | 9,960 | -90 | -0.9% | 55,600 |
2020/02/12 | 10,030 | 10,110 | 9,990 | 10,050 | +50 | +0.5% | 35,400 |
2020/02/10 | 9,950 | 10,200 | 9,940 | 10,000 | -50 | -0.5% | 79,700 |
2020/02/07 | 10,030 | 10,060 | 9,930 | 10,050 | +10 | +0.1% | 94,200 |
2020/02/06 | 10,120 | 10,170 | 9,930 | 10,040 | +70 | +0.7% | 77,200 |
2020/02/05 | 9,690 | 9,980 | 9,670 | 9,970 | +400 | +4.2% | 108,600 |
2020/02/04 | 9,430 | 9,570 | 9,340 | 9,570 | +140 | +1.5% | 77,800 |
2020/02/03 | 9,310 | 9,580 | 9,300 | 9,430 | -60 | -0.6% | 92,300 |
2020/01/31 | 9,560 | 9,620 | 9,340 | 9,490 | +320 | +3.5% | 136,300 |
2020/01/30 | 9,450 | 9,490 | 9,100 | 9,170 | -370 | -3.9% | 132,600 |
2020/01/29 | 9,550 | 9,610 | 9,400 | 9,540 | -30 | -0.3% | 69,900 |
2020/01/28 | 9,460 | 9,650 | 9,430 | 9,570 | +20 | +0.2% | 101,700 |
2020/01/27 | 9,410 | 9,580 | 9,380 | 9,550 | -10 | -0.1% | 66,300 |
2020/01/24 | 9,470 | 9,560 | 9,400 | 9,560 | +100 | +1.1% | 61,900 |
2020/01/23 | 9,440 | 9,500 | 9,380 | 9,460 | +70 | +0.7% | 80,800 |
2020/01/22 | 9,410 | 9,490 | 9,350 | 9,390 | -60 | -0.6% | 60,700 |
2020/01/21 | 9,380 | 9,460 | 9,310 | 9,450 | +30 | +0.3% | 44,500 |
2020/01/20 | 9,370 | 9,450 | 9,320 | 9,420 | +20 | +0.2% | 53,900 |
2020/01/17 | 9,450 | 9,450 | 9,310 | 9,400 | ±0 | ±0% | 47,100 |
2020/01/16 | 9,390 | 9,460 | 9,280 | 9,400 | +10 | +0.1% | 60,800 |
2020/01/15 | 9,450 | 9,450 | 9,320 | 9,390 | +60 | +0.6% | 41,700 |
2020/01/14 | 9,500 | 9,500 | 9,290 | 9,330 | -220 | -2.3% | 99,300 |
2020/01/10 | 9,500 | 9,630 | 9,410 | 9,550 | +150 | +1.6% | 92,900 |
2020/01/09 | 8,990 | 9,440 | 8,970 | 9,400 | +500 | +5.6% | 177,800 |
2020/01/08 | 8,830 | 8,940 | 8,740 | 8,900 | +110 | +1.3% | 138,600 |
2020/01/07 | 8,710 | 8,850 | 8,660 | 8,790 | +230 | +2.7% | 126,300 |
2020/01/06 | 8,750 | 8,770 | 8,540 | 8,560 | -300 | -3.4% | 116,700 |
2019/12/30 | 8,740 | 8,870 | 8,620 | 8,860 | +120 | +1.4% | 83,000 |
2019/12/27 | 8,710 | 8,800 | 8,620 | 8,740 | +80 | +0.9% | 59,400 |
2019/12/26 | 8,710 | 8,710 | 8,610 | 8,660 | -90 | -1% | 98,100 |
1151~
1200
件表示中 / 6840件
類似銘柄と比較する
現在ご覧いただいている「JCRファーマ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
JCRファーマ | 72,400円 | -3.7% | -36.7% | 2.76% | 23.84倍 | 1.56倍 |
|
ヒト成長ホルモン製剤が主力、バイオ後続品も成長。希少疾病のバイオ新薬開発にも取り組む |
ネクセラファーマ | 113,200円 | +197.7% | - | 0.00% | 46.26倍 | 1.48倍 |
|
創薬ベンチャー老舗。買収で成長。英国の創薬事業に日本が柱の後期治験・製造販売事業加わる |
杏林製薬 | 149,900円 | +3.2% | +4.5% | 3.47% | 17.22倍 | 0.66倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
栄研化 | 209,200円 | +0.4% | -8.4% | 2.53% | 27.65倍 | 1.57倍 |
|
臨床検査薬大手。便潜血検査試薬(FIT)はシェア7割。尿検査(ウロ)、遺伝子検査も育成 |
サンバイオ | 96,500円 | - | - | 0.00% | - | 48.59倍 |
|
脳疾患向け再生細胞薬の開発・製造・販売目指すバイオベンチャー。米国で創業し日本に逆上陸 |
市場注目の銘柄
チャート関連のコラム